Top compounds associated with response to WDR4


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.16 4e-06
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.18 5e-05
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.2 6e-05
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.14 9e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA UNC0638 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA XMD11-85h GDSC1000 pan-cancer AAC -0.18 0.0001
mRNA thapsigargin gCSI pan-cancer AAC 0.22 0.0002
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.14 0.0002
Download CSV